346 related articles for article (PubMed ID: 30794302)
1. Effect of Dexamethasone on Nocturnal Oxygenation in Lowlanders With Chronic Obstructive Pulmonary Disease Traveling to 3100 Meters: A Randomized Clinical Trial.
Furian M; Lichtblau M; Aeschbacher SS; Estebesova B; Emilov B; Sheraliev U; Marazhapov NH; Mademilov M; Osmonov B; Bisang M; Ulrich S; Latshang TD; Ulrich S; Sooronbaev TM; Bloch KE
JAMA Netw Open; 2019 Feb; 2(2):e190067. PubMed ID: 30794302
[TBL] [Abstract][Full Text] [Related]
2. Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters: A Randomized Clinical Trial.
Tan L; Latshang TD; Aeschbacher SS; Huber F; Flueck D; Lichtblau M; Ulrich S; Hasler ED; Scheiwiller PM; Ulrich S; Bloch KE; Furian M
JAMA Netw Open; 2020 Jun; 3(6):e207940. PubMed ID: 32568400
[TBL] [Abstract][Full Text] [Related]
3. Right-to-left shunts in lowlanders with COPD traveling to altitude: a randomized controlled trial with dexamethasone.
Lichtblau M; Furian M; Aeschbacher SS; Bisang M; Sheraliev U; Mademilov M; Marazhapov NH; Ulrich S; Sooronbaev T; Bloch KE; Ulrich S
J Appl Physiol (1985); 2020 Jan; 128(1):117-126. PubMed ID: 31751183
[TBL] [Abstract][Full Text] [Related]
4. Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial.
Latshang TD; Nussbaumer-Ochsner Y; Henn RM; Ulrich S; Lo Cascio CM; Ledergerber B; Kohler M; Bloch KE
JAMA; 2012 Dec; 308(22):2390-8. PubMed ID: 23232895
[TBL] [Abstract][Full Text] [Related]
5. Sleep and breathing disturbances in patients with chronic obstructive pulmonary disease traveling to altitude: a randomized trial.
Latshang TD; Tardent RPM; Furian M; Flueck D; Segitz SD; Mueller-Mottet S; Kohler M; Ulrich S; Bloch KE
Sleep; 2019 Jan; 42(1):. PubMed ID: 30517695
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone improves pulmonary hemodynamics in COPD-patients going to altitude: A randomized trial.
Lichtblau M; Furian M; Aeschbacher SS; Bisang M; Ulrich S; Saxer S; Sheraliev U; Marazhapov NH; Osmonov B; Estebesova B; Sooronbaev T; Bloch KE; Ulrich S
Int J Cardiol; 2019 May; 283():159-164. PubMed ID: 30638985
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Dexamethasone in Preventing Acute Mountain Sickness in COPD Patients: Randomized Trial.
Furian M; Lichtblau M; Aeschbacher SS; Estebesova B; Emilov B; Sheraliev U; Marazhapov NH; Mademilov M; Osmonov B; Bisang M; Ulrich S; Latshang TD; Ulrich S; Sooronbaev TM; Bloch KE
Chest; 2018 Oct; 154(4):788-797. PubMed ID: 29909285
[TBL] [Abstract][Full Text] [Related]
8. Effect of altitude and acetazolamide on sleep and nocturnal breathing in healthy lowlanders 40 y of age or older. Data from a randomized trial.
Graf LC; Furian M; Bitos K; Mademilov M; Abdraeva A; Buenzli J; Buenzli S; Aidaralieva S; Sheraliev U; Mayer LC; Schneider SR; Sooronbaev TM; Ulrich S; Bloch KE
Sleep; 2023 Apr; 46(4):. PubMed ID: 36356042
[TBL] [Abstract][Full Text] [Related]
9. Nocturnal cerebral tissue oxygenation in lowlanders with chronic obstructive pulmonary disease travelling to an altitude of 2,590 m: Data from a randomised trial.
Furian M; Flueck D; Scheiwiller PM; Mueller-Mottet S; Urner LM; Latshang TD; Ulrich S; Bloch KE
J Sleep Res; 2021 Dec; 30(6):e13365. PubMed ID: 33902162
[TBL] [Abstract][Full Text] [Related]
10. Effect of One Night of Nocturnal Oxygen Supplementation on Highland Patients With OSA: A Randomized, Crossover Trial.
Tan L; Li T; Zhang Y; He D; Luo L; Lei F; Ren R; He J; Bloch KE; Tang X
Chest; 2021 Aug; 160(2):690-700. PubMed ID: 33667495
[TBL] [Abstract][Full Text] [Related]
11. Effect of nocturnal oxygen therapy on exercise performance of COPD patients at 2048 m: data from a randomized clinical trial.
Gutweniger S; Latshang TD; Aeschbacher SS; Huber F; Flueck D; Lichtblau M; Ulrich S; Hasler ED; Scheiwiller PM; Ulrich S; Bloch KE; Furian M
Sci Rep; 2021 Oct; 11(1):20355. PubMed ID: 34645842
[TBL] [Abstract][Full Text] [Related]
12. Sleep and breathing in high altitude pulmonary edema susceptible subjects at 4,559 meters.
Nussbaumer-Ochsner Y; Schuepfer N; Ursprung J; Siebenmann C; Maggiorini M; Bloch KE
Sleep; 2012 Oct; 35(10):1413-21. PubMed ID: 23024440
[TBL] [Abstract][Full Text] [Related]
13. Nocturnal Heart Rate and Cardiac Repolarization in Lowlanders With Chronic Obstructive Pulmonary Disease at High Altitude: Data From a Randomized, Placebo-Controlled Trial of Nocturnal Oxygen Therapy.
Bisang M; Latshang TD; Aeschbacher SS; Huber F; Flueck D; Lichtblau M; Ulrich S; Hasler ED; Scheiwiller PM; Ulrich S; Bloch KE; Furian M
Front Med (Lausanne); 2021; 8():557369. PubMed ID: 33732710
[No Abstract] [Full Text] [Related]
14. Cerebral oxygenation in patients with OSA: effects of hypoxia at altitude and impact of acetazolamide.
Ulrich S; Nussbaumer-Ochsner Y; Vasic I; Hasler E; Latshang TD; Kohler M; Muehlemann T; Wolf M; Bloch KE
Chest; 2014 Aug; 146(2):299-308. PubMed ID: 24811331
[TBL] [Abstract][Full Text] [Related]
15. Postural Control in Lowlanders With COPD Traveling to 3100 m: Data From a Randomized Trial Evaluating the Effect of Preventive Dexamethasone Treatment.
Muralt L; Furian M; Lichtblau M; Aeschbacher SS; Clark RA; Estebesova B; Sheraliev U; Marazhapov N; Osmonov B; Bisang M; Ulrich S; Latshang TD; Ulrich S; Sooronbaev TM; Bloch KE
Front Physiol; 2018; 9():752. PubMed ID: 29988503
[No Abstract] [Full Text] [Related]
16. Patients with Obstructive Sleep Apnea Have Cardiac Repolarization Disturbances when Travelling to Altitude: Randomized, Placebo-Controlled Trial of Acetazolamide.
Latshang TD; Kaufmann B; Nussbaumer-Ochsner Y; Ulrich S; Furian M; Kohler M; Thurnheer R; Saguner AM; Duru F; Bloch KE
Sleep; 2016 Sep; 39(9):1631-7. PubMed ID: 27306264
[TBL] [Abstract][Full Text] [Related]
17. Acetazolamide to Prevent Adverse Altitude Effects in COPD and Healthy Adults.
Furian M; Mademilov M; Buergin A; Scheiwiller PM; Mayer L; Schneider S; Emilov B; Lichtblau M; Bitos K; Muralt L; Groth A; Reiser AE; Sevik A; Sheraliev U; Marazhapov NH; Aydaralieva S; Muratbekova A; Tabyshova A; Abdraeva A; Buenzli S; Sooronbaev TM; Ulrich S; Bloch KE
NEJM Evid; 2022 Jan; 1(1):EVIDoa2100006. PubMed ID: 38296630
[TBL] [Abstract][Full Text] [Related]
18. Patients with obstructive sleep apnea syndrome benefit from acetazolamide during an altitude sojourn: a randomized, placebo-controlled, double-blind trial.
Nussbaumer-Ochsner Y; Latshang TD; Ulrich S; Kohler M; Thurnheer R; Bloch KE
Chest; 2012 Jan; 141(1):131-138. PubMed ID: 21659435
[TBL] [Abstract][Full Text] [Related]
19. Effects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease.
Sun H; Palcza J; Rosenberg R; Kryger M; Siringhaus T; Rowe J; Lines C; Wagner JA; Troyer MD
Respir Med; 2015 Mar; 109(3):416-26. PubMed ID: 25661282
[TBL] [Abstract][Full Text] [Related]
20. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.
Mason M; Cates CJ; Smith I
Cochrane Database Syst Rev; 2015 Jul; (7):CD011090. PubMed ID: 26171909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
